1393 related articles for article (PubMed ID: 33081731)
21. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Jin Y; Yang Y
Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
[TBL] [Abstract][Full Text] [Related]
22. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
23. Six-gene signature for predicting survival in patients with head and neck squamous cell carcinoma.
Wang J; Chen X; Tian Y; Zhu G; Qin Y; Chen X; Pi L; Wei M; Liu G; Li Z; Chen C; Lv Y; Cai G
Aging (Albany NY); 2020 Jan; 12(1):767-783. PubMed ID: 31927533
[TBL] [Abstract][Full Text] [Related]
24. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
25. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas.
Ma B; Li H; Qiao J; Meng T; Yu R
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959
[TBL] [Abstract][Full Text] [Related]
26. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.
Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q
Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755
[TBL] [Abstract][Full Text] [Related]
27. An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma.
Chen Y; Luo TQ; Xu SS; Chen CY; Sun Y; Lin L; Mao YP
Cancer Med; 2021 Apr; 10(7):2268-2285. PubMed ID: 33660378
[TBL] [Abstract][Full Text] [Related]
28. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
[TBL] [Abstract][Full Text] [Related]
29. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
30. Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma.
He J; Fang X; Han M
Front Genet; 2021; 12():654657. PubMed ID: 34108990
[TBL] [Abstract][Full Text] [Related]
31. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Cui L
J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
[TBL] [Abstract][Full Text] [Related]
32. Integrative Bioinformatics Analysis Identifies NEK2 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma.
Liu S; Tian W; Li B
J Comput Biol; 2020 Jan; 27(1):100-108. PubMed ID: 31460782
[TBL] [Abstract][Full Text] [Related]
33. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
Chen L; Cai Z; Lyu K; Cai Z; Lei W
Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory response-related genes predict prognosis in patients with HNSCC.
Jing SL; Afshari K; Guo ZC
Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
[TBL] [Abstract][Full Text] [Related]
35. Immune-related genes have prognostic significance in head and neck squamous cell carcinoma.
Yang J; Xie K; Li C
Life Sci; 2020 Sep; 256():117906. PubMed ID: 32504750
[TBL] [Abstract][Full Text] [Related]
36. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
Zhong Q; Zhou L; Zhu D
J Oral Pathol Med; 2021 Oct; 50(9):891-901. PubMed ID: 33880801
[TBL] [Abstract][Full Text] [Related]
37. Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset.
Wu C; Tong L; Wu C; Chen D; Chen J; Li Q; Jia F; Huang Z
Cancer Med; 2020 Apr; 9(8):2631-2642. PubMed ID: 32064753
[TBL] [Abstract][Full Text] [Related]
38. Identification novel prognostic signatures for Head and Neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.
Zhou H; He Y; Li L; Wu C; Hu G
Int J Med Sci; 2021; 18(5):1297-1311. PubMed ID: 33526991
[No Abstract] [Full Text] [Related]
39. Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma.
Chen L; Zeng H; Zhang M; Luo Y; Ma X
Cancer Med; 2021 Jul; 10(13):4615-4628. PubMed ID: 33987946
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]